DS
HSCS icon

DRW Securities’s Heart Test Laboratories HSCS Stock Holding History

DRW Securities’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$192K Sell
76,450
-18,615
-20% -$54.2K ﹤0.01% 1128
2025
Q4 		$294K Buy
95,065
+11,455
+14% +$34K 0.01% 693
2025
Q3 		$291K Buy
+83,610
New +$304K 0.01% 861

Other funds holding HSCS

TA
TFB Advisors Overland Park, Kansas $191M AUM 18.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.41B AUM 19.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

DRW Securities's HSCS Position: Q1 2026 in Review

DRW Securities reduced its Heart Test Laboratories (HSCS) stake by 20% in Q1 2026, selling an estimated $54.2K and leaving 76,450 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #1128.

DRW Securities first reported a position in HSCS in Q3 2025 and has held it in 3 quarters since. The position peaked at $294K in Q4 2025. 13 funds tracked by Wall St. Rank hold HSCS as of Q1 2026.

  • DRW Securities held 76,450 shares of Heart Test Laboratories worth $192K as of Q1 2026.
  • DRW Securities sold 18,615 Heart Test Laboratories shares in Q1 2026, an estimated $54.2K.
  • Heart Test Laboratories made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #1128 holding.
  • DRW Securities first reported a position in Heart Test Laboratories in Q3 2025 and has held it in 3 quarters since.
  • DRW Securities's Heart Test Laboratories position peaked at $294K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.